Proliferation and invasion factors in HIV-associated dysplastic and nondysplastic oral warts and in oral squamous cell carcinoma: An immunohistochemical and RT-PCR evaluation

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 94, Issue 6, 2002, Pages 724-731

  Regezi, Joseph A ^a,b,c   Dekker, Nusi P ^a,b   Ramos, Daniel M ^a,b   Li, Xiaowu ^b   Macabeo Ong, Maricris ^a,b   Jordan, Richard C K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTEGRIN; BETA6 INTEGRIN; INTERSTITIAL COLLAGENASE; KI 67 ANTIGEN; RNA; TENASCIN; VIRUS ANTIGEN;

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL DIVISION; CELL TRANSFORMATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PAPILLOMA VIRUS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS;

ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, VIRAL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA CHAINS; KI-67 ANTIGEN; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TENASCIN; WARTS;

EID: 0036885795     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2002.129760     Document Type: Article

References (22)

1. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001;5:1411-2.
2. King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002;34:641-8.
3. Regezi JA, Greenspan D, Greenspan JS, Wong E, MacPhail LA. HPV-associated epithelial atypia in oral warts in HIV+ patients. J Cutan Pathol 1994;21:217-23.
4. Breuss JM, Gallo J, Delisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, et al. Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995;108:2241-51.
5. Curran S, Murray GI. Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 1999;189:300-8.
6. Jones J, Watt FM, Speight PM. Changes in the expression of αv integrins in oral squamous cell carcinomas. J Oral Pathol 1997;26:63-8.
7. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kameyama T, Morimatsu M. The significance of epidermal growth factor receptor and matrix metalloproteinases-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncology 1996; 32B:217-21.
8. Kurahara S, Shinohara M, Lkebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K. Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 199;21:627-38.
9. Ramos DM, Chen BL, Boylen K, Stern M, Kramer RH, Sheppard D, et al. Stromal fibroblasts influence oral squamous cell carcinoma cell interactions with tenascin-C. Int J Cancer 1997;72:369-76.
10. Ramos DM, Chen B, Regezi J, Zardi L, Pytela R. Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 1998;75:680-7.
11. Shrestha P, Sakamoto F, Takagi H, Yamada T, Mori M. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study. Oral Oncol, Eur J Cancer 1994;30B:132-7.
12. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T. Expression of matrix metalloproteinases (MMP1 and MMP2) and their inhibitors (TIMP1,2,3) in oral lichen planus, dysplasia, squamous cell carcinoma, and lymph node metastasis. Br J Cancer 1998;77:2239-45.
13. Tiitta O, Happonen RP, Virtanen I, Luomanen M. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. J Oral Pathol Med 1994;23:446-50.
14. Huang X, Wu J, Zhu W, Pytela R, Sheppard D. Expression of the human integrin β6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in β6 knockout mice. Am J Respir Cell Mol Biol 1998;19:636-42.
15. Macabeo-Ong M, Ginzinger DG, Dekker NP, McMillan A, Regezi JA, Wong DTW, et al. Effect of formalin fixation time on tissues for quantitative mRNA expression analysis. Modern Pathol 2002;15:979-87.
16. Godfrey TE, Kim SH, Chavira M, Ruff DW, Warren RS, Gray JW, et al. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription- polymerase chain reaction. J Mol Diagn 2000;2:84-91.
17. PE Applied Biosystems. ABE Prism 7700 detection system: relative quantitation of gene expression. User bulletin #2. 36. 2001. Norwalk, Conn; 1997.
18. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000;60:5405-9.
19. Walker RA. The histochemistry of glycosidases in human benign and malignant breast tissue. J Pathol 1984;143:39-50.
20. Fornatora M, Cale Jones A, Kerpel S, Freedman P. Human papillomavirus-associated oral epithelial dysplasia (koilocytic dysplasia): an entity of unknown biologic potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:47-56.
21. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8:4099-105.
22. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus Types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.